|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, August 23, 2017 ) North America accounted to have largest share in the market owing to increasing adoption of low cost immunoassay instruments in research and clinical laboratories, rising application of immunoassay techniques in cancer research.
Immunoassays are accurate and quick tests that can be used on-site/in laboratory to identify specific molecules. Immunoassays depends on inherent ability of an antibody to attach to the specific structure of a molecule. Antibodies are the proteins generated in response to the invasion of an antigen into the body. Antibodies are found in blood and tissue fluids and will bind to the antigen whenever it is encountered. Because antibodies are developed to a specific three-dimensional structure of an analyte, that are highly specific and will bind only to that structure.
Get a comprehensive overview of the North America Immunoassays Market:
http://www.marketdataforecast.com/market-reports/north-america-immunoassays-market-1568/
North America immunoassays market is primarily driven by rising prevalence of infectious diseases, increasing ageing population, advancements in novel assays in various diseases such as Cardiology and oncology, growing applications in diagnosting drug monitoring tests, infectious diseases and identification of cancer biomarkers, increasing need of reagents, sensitive assays and analytical techniques, availability of wide range of reagents, introduction of novel biomarkers, growing government and corporate investment in the pharmaceutical and biotechnology segment in emerging markets. Lack of reimbursement policies, adoption of immunoassays in emerging markets, stringent regulations for storage are limiting the growth of the market.
Get accurate market forecast and analysis on the North America Immunoassays Market. Request a sample to stay up-to-date on the main trends affecting this market:
http://www.marketdataforecast.com/market-reports/north-america-immunoassays-market-1568/request-sample
Based on Technology, the market is segmented into Enzyme Immunoassay, Fluorescent Immunoassays, Cheniluminescence Immunoassays, Nephelometric Immunoassays, Radio Immunoassays, Counting Immunoassays, Turbidimetric Immunoassays, and Others. Based on Application, the market is segmented into oncology, Cancer, Hematology, Cardiology, Thyroid, Infectious diseases, Allergies and others. Based on End users, the market is segmented into Hospitals, clinics, Academic Research institute, Pharmaceutical and Biotech vendors, Laboratories and others. Based on Geography, the North America Immunoassays market is analysed under various regions namely U.S, and Canada.
Inquire Before buying:
http://www.marketdataforecast.com/market-reports/north-america-immunoassays-market-1568/inquire
Some of the major companies dominating the North America market are Roche Diagnostics, DiaSorin S.p.A, Beckman Coulter, Siemens Healthcare, Ortho Clinical Diagnostics, bioMerieux, Thermo Fisher Scientific and Abbott Laboratories, Akers Biosciences, Inc, Becton Dickinson and Company, Devon Medical Products, EDP Biotech Corporation, Hologic (Gen-Probe), Intrinsic LifeSciences.
About Market Data Forecast:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options. For more information, kindly visit, www.marketdataforecast.com.
Market Data Forecast
Abhishek
+1-888- 702-9626
abhishek@marketdataforecast.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
